Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Wearable Injectors Market Outlook

The global wearable injectors market size reached a value of around USD 7.94 billion in 2023, driven by the rising prevalence of chronic disorders. The market is further expected to grow at a CAGR of 11.9% during the forecast period of 2024-2032, likely to attain a value of around USD 21.86 billion by 2032.

Wearable Injectors: Introduction

Wearable injectors refer to drug delivery devices that are used to deliver drug doses to the body. These drugs are delivered automatically on pre-set doses to the patient on set intervals, which is administered by the physician.

Global Wearable Injectors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Wearable Injectors Market

The growth of the market is significantly being driven by the rising prevalence of chronic diseases like diabetes and cancer, among others. The growth of the market is also being driven by the rapid technological advancements in the healthcare sectors, along with the growing emphasis of the governments on improved healthcare infrastructure and facilities. Higher investment and funding by the governments and healthcare organisations are also providing a significant impetus to the growth of the market.

Global Wearable Injectors Market Analysis

Based on type, the market is divided into type, therapy, end user, and region.

https://www.expertmarketresearch.com/reports/wearable-injectors-market/requestsample

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Type      

  • On-Body Injectors 
  • Off-Body Injectors 

Market Breakup by Therapy 

  • Oncology 
  • Autoimmune Disease 
  • Diabetes 
  • Cardiovascular Disease 
  • Others  

Market Breakup by End User 

  • Hospitals 
  • Diagnostic Centres 
  • Home Care     
  • Others  

Market Breakup by Region 

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

Global Wearable Injectors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Wearable Injectors Market Scenario

The market for wearable injectors has been witnessing robust growth and is anticipated to continue witnessing demand in the coming years with the rapidly developing healthcare sector. Among the regional markets, North America is anticipated to lead the global market as the region has the highest presence of the key players.

Apart from North America, Asia Pacific is also anticipated to register significant growth in the coming years owing to the rising prevalence of chronic conditions in the region, especially amongst the geriatric population. The favourable policies by the government for the use of these devices is likely to bolster the growth of the market.

Competitive Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global wearable injectors market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

  • Amgen  
  • Becton 
  • Dickinson and Company  
  • Dexcom, Inc.  
  • Enable Injections 
  • Insulet Corporation  
  • Sensile Medical 
  • Tandem Diabetes Care  
  • Ypsomed  
  • Johnson & Johnson Services  
  • F. Hoffmann-La Roche Ltd 
  • Unilife Corporation  
  • SteadyMed Therapeutics  
  • Insulet Corporation  
  • CeQur SA

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Therapy
  • End User
  • Region

Breakup by Type

  • On-Body Injectors 
  • Off-Body Injectors 
Breakup by Therapy
  • Oncology 
  • Autoimmune Disease 
  • Diabetes 
  • Cardiovascular Disease 
  • Others  
Breakup by End User
  • Hospitals 
  • Diagnostic Centres 
  • Home Care     
  • Others  
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Amgen  
  • Becton 
  • Dickinson and Company  
  • Dexcom, Inc.  
  • Enable Injections 
  • Insulet Corporation  
  • Sensile Medical 
  • Tandem Diabetes Care  
  • Ypsomed  
  • Johnson & Johnson Services  
  • F. Hoffmann-La Roche Ltd 
  • Unilife Corporation  
  • SteadyMed Therapeutics  
  • Insulet Corporation  
  • CeQur SA

Wearable Injectors Market Report Snapshots

Wearable Injectors Market Size

Wearable Injectors Market Trends

Wearable Injectors Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of USD 7.94 billion in 2023.

The market is anticipated to grow at a CAGR of 11.9% during the forecast period of 2024-2032 to attain a value of around USD 21.86 billion by 2032.

The growth of the market is driven by factors like rising prevalence of chronic disorders and the rapid technological advancements.

The key trends which are bolstering the market growth include the rising investment and funding by the government.

The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The types can be categorized into on-body injectors and off-body injectors.

The therapies in the market include oncology, autoimmune disease, diabetes, and cardiovascular disease, among others.

The end-users in the market include hospitals, diagnostic centres, and home care, among others.

The key players in the market can be categorised into Amgen, Becton, Dickinson and Company, Dexcom, Inc., Enable Injections,     Insulet Corporation, Sensile Medical, Tandem Diabetes Care, Ypsomed, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd, Unilife Corporation, SteadyMed Therapeutics, Insulet Corporation, and CeQur SA.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124